13F Data
13F filer · CIK 1777015

Parkman Healthcare Partners LLC

STAMFORD, CT · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$976.8M
+$7.2M vs prior
Positions
77
New / sold out
18 / 31
Added / reduced
27 / 30
Turnover
28.3%
buys $275.9M · sells $366.9M
Top-10 weight
33.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewINHIBRX BIOSCIENCES INC+256,950–+$24.3M
NewUNITEDHEALTH GROUP INC+55,921–+$23.2M
AddedVIRIDIAN THERAPEUTICS INC+819,640+146.9%+$15.1M
NewINDIVIOR PHARMACEUTICALS INC+364,269–+$14.9M
NewAVALO THERAPEUTICS INC+766,290–+$14.2M
AddedSTRUCTURE THERAPEUTICS INC+253,568+109.3%+$13.6M
AddedBRIGHT MINDS BIOSCIENCES INC+164,955+411.4%+$11.6M
NewALTO NEUROSCIENCE INC+429,035–+$11.3M
NewORUKA THERAPEUTICS INC+113,188–+$10.8M
AddedEDGEWISE THERAPEUTICS INC+254,208+78.7%+$10.3M
35 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outKALVISTA PHARMACEUTICALS INC-1,835,506-100.0%$-36.9M
ReducedSTRYKER CORPORATION-86,798-56.1%$-27.3M
Sold outQIAGEN NV-500,000-100.0%$-20.0M
Sold outABBVIE INC-75,000-100.0%$-16.3M
ReducedLIVANOVA PLC-193,436-47.9%$-15.9M
Sold outILLUMINA INC-110,370-100.0%$-13.6M
Sold outEDWARDS LIFESCIENCES CORP-167,155-100.0%$-13.4M
Sold outNEUROCRINE BIOSCIENCES INC-99,069-100.0%$-13.1M
Sold outKINIKSA PHARMACEUTICALS INTL-259,184-100.0%$-12.5M
ReducedBOSTON SCIENTIFIC CORP-268,287-59.8%$-11.5M
51 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $346.4MQ1 2020: $215.8MQ2 2020: $355.0MQ3 2020: $377.7MQ4 2020: $390.3MQ1 2021: $430.9MQ2 2021: $457.4MQ3 2021: $395.3MQ4 2021: $453.2MQ1 2022: $341.7MQ2 2022: $271.5MQ3 2022: $351.7MQ4 2022: $375.5MQ1 2023: $459.8MQ2 2023: $576.9MQ3 2023: $545.8MQ4 2023: $709.9MQ1 2024: $815.0MQ2 2024: $746.6MQ3 2024: $783.4MQ4 2024: $750.9MQ1 2025: $843.1MQ2 2025: $870.1MQ3 2025: $958.7MQ4 2025: $1.1BQ1 2026: $969.6MQ2 2026: $976.8M
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MBX BIOSCIENCES INCCOM800,173$44.2M4.52%
2LLYELI LILLY & CO35,000$42.0M4.30%
3CVSCVS HEALTH CORP391,791$40.5M4.15%
4DEXCOM INCCOM534,767$36.0M3.69%
5PTC THERAPEUTICS INCCOM435,691$35.5M3.64%
6ARCUS BIOSCIENCES INCCOM919,266$28.3M2.90%
7STRUCTURE THERAPEUTICS INCSPONSORED ADS485,661$26.1M2.67%
8VIRIDIAN THERAPEUTICS INCCOM1,377,576$25.3M2.59%
9AGIOS PHARMACEUTICALS INCCOM669,046$24.8M2.54%
10INHIBRX BIOSCIENCES INCCOM256,950$24.3M2.49%
67 more rows. Subscribe for $29/month to see every row, download the data and use the API.